News

Dapagliflozin reverses myocardial fibrosis in HFpEF with diabetes, suggesting a disease-modifying effect.

Peanut oral immunotherapy (POIT), which involves gradually increasing exposure to peanut protein, has shown promise, successfully desensitising 50–70% of patients.

Discover a study revealing how subclinical liver fibrosis, measured by FIB-4, predicts increased mortality risk in coronary artery disease patients.

Semaglutide and tirzepatide lower risks of dementia, stroke, and death in type 2 diabetes and obesity, new study shows.

UK Biobank’s massive imaging project scans 100,000 people to reveal early disease signs, transforming diagnosis and prevention worldwide.

A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can be safely integrated with bispecific antibody treatment in patients with relapsed or refractory blood cancers…

Cord blood biomarkers may help detect early neonatal sepsis, improving diagnosis and reducing unnecessary antibiotic use in preterm infants.

The WISH-BREAST survey reveals that nearly 90% of breast cancer survivors experience sexual health changes, yet most report receiving no support from their care team.